机译:ParitaPrevir / R / Obsmitasvir Plus dasabuvir在HCV基因型1B中的八周,具有轻度中等纤维化:现实世界队列的结果
Univ Autonoma Barcelona Hosp Mar IMIM Barcelona Spain;
Hosp Univ Getafe Getafe Spain;
Univ Autonoma Barcelona Hosp Mar IMIM Barcelona Spain;
Hosp Gen Valencia Valencia Spain;
Complejo Hosp Univ Pontevedra IIS Galicia Sur Pontevedra Spain;
Hosp Univ Ramon y Cajal CIBERehd Madrid Spain;
Hosp Univ Virgen del Rocio Seville Spain;
Univ Barcelona Hosp Clin IDIBAPS CIBERehd Barcelona Spain;
Hosp Marques de Valdecilla Santander Spain;
Hosp Univ Burgos Burgos Spain;
Hosp Carlos III La Paz Madrid Spain;
Hosp Badalona Germans Trias &
Pujol CIBERehd Badalona Spain;
Hosp Santa Creu &
Sant Pau CIBERehd Barcelona Spain;
Hosp Univ Joan XXIII Tarragona Spain;
Hosp Virgen de la Macarena Seville Spain;
Hosp Severo Ochoa Leganes Spain;
Hosp Univ San Cecilio Granada Spain;
Ctr Hosp Santiago de Compostela Santiago De Compostela Spain;
Hosp Univ Toledo Toledo Spain;
Hosp Gen Segovia Segovia Spain;
Hosp Univ Dr Peset Valencia Spain;
Ctr Hosp Univ Albacete Albacete Spain;
Hosp San Agustin Aviles Spain;
Hosp Univ Puerta de Hierro Majadahonda Madrid Spain;
Univ Autonoma Barcelona Hosp Mar IMIM Barcelona Spain;
dasabuvir; ombitasvir; paritaprevir; sustained virological response;
机译:ParitaPrevir / R / Obsmitasvir Plus dasabuvir在HCV基因型1B中的八周,具有轻度中等纤维化:现实世界队列的结果
机译:临床显着门诊高血压(第BaveNo 2)对ParitaPrevir,Ritonavir,ObsitaSvir,Dasbuvir和利巴韦林(Prod Plus R)的安全,耐受性和功效的影响,在实际群体的基因型1B HCV肝硬化患者中
机译:Hybalasvir / ParitaPrevir / Ritonavir和Dasbuvir的高疗效在利韦林治疗基因型1B HCV感染的肝硬化患者中的12周:一个大型世界队列
机译:Paritaprevir / ritonavirombitasvir和dasabuvir联合利巴韦林治疗70岁以上HCV基因型1b代偿性肝硬化的疗效和安全性
机译:接受ombitasvir / paritaprevir / r和dasabuvir联合治疗的HCV基因型1b肝硬化患者的100%持续病毒学应答持续12周